Big Pharma’s report cards just rewrote the market mood. Market View dives into why Pfizer slipped into a quarterly loss, why Novo Nordisk plunged double digits, and how Merck managed to buck the trend. We also unpack Singtel’s rally on acquisition chatter and what it signals for Singapore’s telco strategy. Across the Pacific, tech stocks drag Wall Street lower as Nvidia and Microsoft weigh on the NASDAQ. Plus, our UP or DOWN game covers PayPal, PepsiCo, Walmart and Intel’s GPU ambitions. All this and more, hosted by Michelle Martin with Ryan Huang.See omnystudio.com/listener for privacy information.

Big Pharma&rsquo;s report cards just rewrote the market mood. Market View dives into why Pfizer slipped into a quarterly loss, why Novo Nordisk plunged double digits, and how Merck managed to buck the trend. We also unpack Singtel&rsquo;s rally on acquisition chatter and what it signals for Singapore&rsquo;s telco strategy. Across the Pacific, tech stocks drag Wall Street lower as Nvidia and Microsoft weigh on the NASDAQ. Plus, our UP or DOWN game covers PayPal, PepsiCo, Walmart and Intel&rsquo;s GPU ambitions. All this and more, hosted by Michelle Martin with Ryan Huang.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Market View: Pharma Shockwaves, Singtel’s Deal Buzz & Big Tech’s Slide